Avalon Blogging Company Funding 
socalTECH
JANUARY 17, 2011
San Diego-based venture capital firm Avalon Ventures has boosted an Internet web site publisher known for its humorous, captioned pictures of cats and use of Internet memes, Cheezburger. which features "LOLcats", funny pictures of cats with humorous captions, and FAIL Blog , a site which highlights "fails".
Xconomy
SEPTEMBER 27, 2016
[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m. Bregua Corp.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
SEPTEMBER 11, 2019
GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.
Xconomy
AUGUST 17, 2016
San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. and San Diego’s Avalon Ventures.
Xconomy
JULY 20, 2016
First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. It’s a little like what Avalon is doing. But so far, the company has actually drawn only $3 million last year and $4 million earlier this year. (The
Xconomy
JULY 19, 2016
Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. Existing investors Avalon Ventures and Correlation Ventures joined in the round.
Xconomy
JULY 10, 2016
Bock, who died last Wednesday at 56, was a life sciences entrepreneur and investor who helped start or finance dozens of companies that have a combined market value estimated today at roughly $70 billion. He really enjoyed the process of putting companies together himself,” she said Friday. “He He had great fun doing his companies.
Expert insights. Personalized for you.
160 
Let's personalize your content